Revelation Biosciences Inc.
13F holders, Q4 2024 (December 31)9holders +2
5new positions
3sold out
$0.46avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Revelation Biosciences Inc. in their 13F filings, up 2 from Q3 2024. 5 opened new positions and 3 sold out. The largest holders were XTX Topco Ltd ($23K), Two Sigma Securities, LLC ($13K) and StoneX Group Inc. ($7K).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L507
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $48K |
| Exits | 3 | $82K |
All 13F filers, Q3 2024 → Q4 2024: 104,376 shares bought and 96,439 shares sold, net +7,937 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| XTX Topco Ltd | 0.00% | New | 49,840 | $23K |
| Two Sigma Securities, LLC | 0.00% | New | 29,102 | $13K |
| StoneX Group Inc. | 0.00% | New | 14,137 | $7K |
| Geode Capital Management, LLC | 0.00% | New | 10,964 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.4% | 2,529 | $1K |
| Bank of America Corp. | 0.00% | Add +803.5% | 262 | $121 |
| Morgan Stanley | 0.00% | No change | 6 | $3 |
| Royal Bank of Canada | 0.00% | New | 100 | $0 |
| POM Investment Strategies, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.